- Home
- QGEN vs MASI Comparison
QGEN vs MASI Comparison
Compare QGEN & MASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QGEN
- MASI
- Stock Information
- Founded
- QGEN 1986
- MASI 1989
- Country
- QGEN Netherlands
- MASI United States
- Employees
- QGEN N/A
- MASI N/A
- Industry
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- MASI Medical/Dental Instruments
- Sector
- QGEN Health Care
- MASI Health Care
- Exchange
- QGEN Nasdaq
- MASI Nasdaq
- Market Cap
- QGEN 9.9B
- MASI 9.0B
- IPO Year
- QGEN 1996
- MASI 2007
- Fundamental
- Price
- QGEN $40.04
- MASI $171.48
- Analyst Decision
- QGEN Buy
- MASI Buy
- Analyst Count
- QGEN 8
- MASI 6
- Target Price
- QGEN $49.79
- MASI $194.80
- AVG Volume (30 Days)
- QGEN 1.1M
- MASI 545.1K
- Earning Date
- QGEN 04-28-2025
- MASI 05-06-2025
- Dividend Yield
- QGEN 3.31%
- MASI N/A
- EPS Growth
- QGEN N/A
- MASI N/A
- EPS
- QGEN 0.38
- MASI N/A
- Revenue
- QGEN $1,978,214,000.00
- MASI $2,094,400,000.00
- Revenue This Year
- QGEN $5.15
- MASI N/A
- Revenue Next Year
- QGEN $6.49
- MASI $7.82
- P/E Ratio
- QGEN $103.78
- MASI N/A
- Revenue Growth
- QGEN 0.66
- MASI 2.26
- 52 Week Low
- QGEN $37.63
- MASI $101.61
- 52 Week High
- QGEN $47.93
- MASI $194.88
- Technical
- Relative Strength Index (RSI)
- QGEN 51.72
- MASI 50.74
- Support Level
- QGEN $39.31
- MASI $159.29
- Resistance Level
- QGEN $40.27
- MASI $169.82
- Average True Range (ATR)
- QGEN 0.55
- MASI 5.72
- MACD
- QGEN 0.16
- MASI 0.21
- Stochastic Oscillator
- QGEN 82.59
- MASI 75.67
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).
About MASI Masimo Corporation
Masimo Corp is a global technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.